Two Currently Available Medications – an Antifungal and an Antidepressant – May Help Protect Against COVID-19

Doctor Thumbs Up

New analysis printed within the British Journal of Pharmacology signifies that two at the moment accessible medicines — an antifungal drug and an antidepressant — can successfully inhibit the virus that causes COVID-19 in laboratory cells.

Investigators discovered that the antifungal itraconazole and the antidepressant fluoxetine every blocked the manufacturing of infectious SARS-CoV-2 virus in cell tradition lab assessments. When both drug was utilized in mixture with the antiviral drug remdesiver, the mix confirmed synergistic results and inhibited the manufacturing of SARS-CoV-2 by greater than 90%.

“Preventive vaccination and therapeutic medicines in opposition to COVID-19 are each required to successfully fight pandemics brought on by rising zoonotic viruses similar to SARS-CoV-2,” stated senior writer Ursula Rescher, PhD, of the College of Muenster, in Germany.

Reference: “Drug synergy of combinatory remedy with remdesivir and the repurposed medicine fluoxetine and itraconazole successfully impairs SARS‐CoV‐2 an infection in vitro” by Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano, Shuyu Zheng, Jing Tang, Stephan Ludwig and Ursula Rescher, 6 April 2021, British Journal of Pharmacology.
Back to top button